FineMark National Bank & Trust’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-2,747
| Closed | -$214K | – | 435 |
|
2024
Q3 | $214K | Buy |
+2,747
| New | +$214K | 0.01% | 399 |
|
2023
Q3 | – | Sell |
-3,285
| Closed | -$235K | – | 417 |
|
2023
Q2 | $235K | Buy |
+3,285
| New | +$235K | 0.01% | 384 |
|
2015
Q4 | – | Sell |
-2,512
| Closed | -$80K | – | 1354 |
|
2015
Q3 | $80K | Sell |
2,512
-204
| -8% | -$6.5K | 0.01% | 506 |
|
2015
Q2 | $86K | Buy |
2,716
+2,548
| +1,517% | +$80.7K | 0.01% | 521 |
|
2015
Q1 | $6K | Sell |
168
-660
| -80% | -$23.6K | ﹤0.01% | 1091 |
|
2014
Q4 | $29K | Buy |
828
+660
| +393% | +$23.1K | ﹤0.01% | 815 |
|
2014
Q3 | $6K | Sell |
168
-336
| -67% | -$12K | ﹤0.01% | 1096 |
|
2014
Q2 | $18K | Sell |
504
-3,582
| -88% | -$128K | ﹤0.01% | 916 |
|
2014
Q1 | $133K | Sell |
4,086
-130
| -3% | -$4.23K | 0.02% | 388 |
|
2013
Q4 | $125K | Sell |
4,216
-2,044
| -33% | -$60.6K | 0.03% | 390 |
|
2013
Q3 | $163K | Buy |
6,260
+1,264
| +25% | +$32.9K | 0.04% | 335 |
|
2013
Q2 | $118K | Buy |
+4,996
| New | +$118K | 0.04% | 369 |
|